GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Total Liabilities

Tci Gene (ROCO:6879) Total Liabilities : NT$155.5 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Total Liabilities?

Tci Gene's Total Liabilities for the quarter that ended in Dec. 2023 was NT$155.5 Mil.

Tci Gene's quarterly Total Liabilities increased from Dec. 2022 (NT$143.17 Mil) to Jun. 2023 (NT$221.27 Mil) but then declined from Jun. 2023 (NT$221.27 Mil) to Dec. 2023 (NT$155.55 Mil).

Tci Gene's annual Total Liabilities declined from Dec. 2021 (NT$169.44 Mil) to Dec. 2022 (NT$143.17 Mil) but then increased from Dec. 2022 (NT$143.17 Mil) to Dec. 2023 (NT$155.55 Mil).


Tci Gene Total Liabilities Historical Data

The historical data trend for Tci Gene's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Total Liabilities Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
61.45 99.75 169.44 143.17 155.55

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only 169.44 204.40 143.17 221.27 155.55

Tci Gene Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tci Gene's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=155.548+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=155.5

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=1165.94-1010.392
=155.5

Tci Gene's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=155.548+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=155.5

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=1165.94-1010.392
=155.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tci Gene Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tci Gene's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines